RV Failure: The Great Debates
All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.
Moderators
Subhasis Chatterjee, MD
Nicholas Teman, MD
Disclosure(s): Alexion Pharmaceuticals: Consultant (Ongoing)
Presentations
- Debate 1: RV Failure After MV Surgery—First Line Right-Sided MCS
Michael Tong, MD
Disclosure(s): Abbott: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abiomed: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Lifenet: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
- Debate 1: RV Failure After MV Surgery—First Line VA ECMO
Amy E. Hackmann, MD
Disclosure(s): Medtronic: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness), Advisory Board (Ongoing)
- Rebuttal
- Discussion
- Debate 2: Inhaled Nitric Oxide vs Prostacyclin—Pro Inhaled Nitric Oxide
Vikram Fielding-Singh, MD, JD
Disclosure(s): Masimo: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); SeaStar Medkcal: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
- Debate 2: Inhaled Nitric Oxide vs Prostacyclin—Pro Prostacyclin
Kamrouz Ghadimi, MD MHSc
Disclosure(s): Octapharma: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Up To Date: Consultant (Ongoing), Royalties (Ongoing)
- Rebuttal
- Discussion
- Debate 3: Severe RV Dysfunction Before LVAD - Pro Planned RVAD
Christian Bermudez, MD
Disclosure(s): Abbott: Advisory Board (Ongoing); Abiomed / Breethe: Advisory Board (Ongoing)
- Debate 3: Severe RV Dysfunction Before LVAD - Pro Watch and See
Ashish Shah, MD
- Rebuttal
- Discussion
Available Credit
- 1.50 ABS Accredited CME
- 1.50 ABTS Accredited CME
- 1.50 AMA PRA Category 1 Credit™
Price
Cost:
$0.00
All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.
Moderators
Subhasis Chatterjee, MD
Nicholas Teman, MD
Disclosure(s): Alexion Pharmaceuticals: Consultant (Ongoing)
Presentations
- Debate 1: RV Failure After MV Surgery—First Line Right-Sided MCS
Michael Tong, MD
Disclosure(s): Abbott: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abiomed: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Lifenet: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
- Debate 1: RV Failure After MV Surgery—First Line VA ECMO
Amy E. Hackmann, MD
- Rebuttal
- Discussion
- Debate 2: Inhaled Nitric Oxide vs Prostacyclin—Pro Inhaled Nitric Oxide
Vikram Fielding-Singh, MD, JD
Disclosure(s): Masimo: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); SeaStar Medkcal: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
- Debate 2: Inhaled Nitric Oxide vs Prostacyclin—Pro Prostacyclin
Kamrouz Ghadimi, MD MHSc
Disclosure(s): Octapharma: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Up To Date: Consultant (Ongoing), Royalties (Ongoing)
- Rebuttal
- Discussion
- Debate 3: Severe RV Dysfunction Before LVAD - Pro Planned RVAD
Christian Bermudez, MD
Disclosure(s): Abbott: Advisory Board (Ongoing); Abiomed / Breethe: Advisory Board (Ongoing)
- Debate 3: Severe RV Dysfunction Before LVAD - Pro Watch and See
Ashish Shah, MD
- Rebuttal
- Discussion